ProCE Banner Activity

CDK4/6 Inhibitors in Breast Cancer: An Oncology Nurse’s Toolkit to Enhance Tolerability and Preserve Benefit

Slideset

Access these downloadable slides to learn what oncology nurses need to know regarding the CDK4/6is for breast cancer. Strategies to mitigate CDK4/6i-related adverse events and tactics to ensure adherence and persistence to CDK4/6i therapy are also discussed.

Released: May 05, 2025

Expiration: May 04, 2026

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation